Emerging antiarrhythmic agents: a personal view from the Far East

Bibliography

• Morris GM, Boyett MR. Perspectives – biological pacing, a clinical reality? Ther Adv Cardiovasc Dis 2009;16:479-83
   Google Scholar
• CAST Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12
   PubMed Web of Science ®Google Scholar
• Wyse DG, Waldo AL, DiMarco JP, ; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33
   PubMed Web of Science ®Google Scholar
• Ravens U. Novel pharmacological approaches for antiarrhythmic therapy. Naunyn Schmiedebergs Arch Pharmacol 2010;381:187-93
   PubMed Web of Science ®Google Scholar
• Mason PK, DiMarco JP. New pharmacological agents for arrhythmias. Circ Arrhythmia Electrophysiol 2009;2:588-97
   PubMed Web of Science ®Google Scholar
• Li D, Sun H, Levesque P. Antiarrhythmic drug therapy for atrial fibrillation: focus on atrial selectivity and safety. Cardiovasc Hematol Agents Med Chem 2009;7:64-75
   PubMedGoogle Scholar
• Conway E, Musco S, Kowley PR. New horizon in antiarrhythmic therapy: will novel agents overcome current deficits? Am J Cardiol 2008;102(Suppl):12H-19H
   PubMedGoogle Scholar
• Dobrev D, Nattel S. New antiarrhythmic drugs for treatment of atrial fibrillation. Lancet 2010;375:1212-23
   PubMed Web of Science ®Google Scholar
• Guidelines for risk and prevention of sudden cardiac death (JCS 2005). Circ J 2005;69(Suppl IV):1253-65
   Google Scholar
• Guidelines for drug treatment of arrhythmias (JCS 2009). Homepage of the Japanese Circulation Society
   Google Scholar
• Kodama I, Kamiya K, Toyama J. Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent. Am J Cardiol 1999;84(9A):20R-28R
   PubMed Web of Science ®Google Scholar
• Dobrev D. Atrial Ca2+ handling in atrial fibrillation as an antiarrhythmic drug target. Naunyn Schmideberg Arch Pharmacol 2010;381:195-206
   PubMed Web of Science ®Google Scholar
• Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation mechanism and implication. Circ Arrhythmia Electrophysiol 2008;1:62-73
   PubMed Web of Science ®Google Scholar
• Dobrev D, Nattel S. Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics. J Cardiovas Pharmacol 2008;52:293-9
   PubMed Web of Science ®Google Scholar
• Tanaka H, Hashimoto N. A multiple ion channel blocker, NIP-142, for the treatment of atrial fibrillation. Cardiovasc Drug Rev 2007;25:342-56
   PubMedGoogle Scholar
• Matsuda T, Ito M, Ishimaru S, Blockade by NIP-142, an antiarrhythmic agent, of carbachol-induced atrial action potential shortening and GIRK1/4 channel. J Pharmacol Sci 2006;101:303-10
   PubMed Web of Science ®Google Scholar
• Nagasawa H, Fujiki A, Fujikura N, Effects of a novel class III antiarrhythmic agent, NIP-142, on canine atrial fibrillation and flutter. Circ J 2002;66:185-91
   PubMed Web of Science ®Google Scholar
• Yang Z, Shi G, Li C, Electrophysiologic effects of nicorandil on the guinea pig long QT1 sundrome model. J Cardiovasc Electrophysiol 2004;15:815-20
   PubMed Web of Science ®Google Scholar
• Hashimoto K. Arrhythmia models for drug research: classification of antiarrhythmic drugs. J Pharmacol Sci 2007;103:333-46
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Tsukada T, Matsuda H, Antiarrhythmic and electrophysiological effects of CH-200. Eur J Pharmacol 1977;45:185-94
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Satoh H, Shibuya T, Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia. J Pharmacol Exp Ther 1982;223:801-10
   PubMed Web of Science ®Google Scholar
• Nishida K, Michael G, Dobrev D, Nattel S. Animal models for atrial fibrillation: clinical insights and scientific opportunities. Europace 2010;12:160-72
   PubMed Web of Science ®Google Scholar
• Yang BF. Research on the antiarrhythmic mechanisms of traditional Chinese medicine in China. Clin Exp Pharmacol Physiol Submitted for publication
   Google Scholar
• An W, Yang J. Protective effects of Ping-Lv-Mixture (PLM), a medicinal formula on arrhythmias induced by myocardial ischemia-reperfusion. J Ethnopharmacol 2006;108:90-5
   PubMed Web of Science ®Google Scholar
• Liu JX, Shang XH, Wang G. Effect of tongxinluo capsule on experimental myocardial ischemia, arrhythmia and hyperlipidemia. Zhongguo Zhong Xi Yi Jie He Za Zhi 1997;17:425-8
   PubMedGoogle Scholar
• Tan S, Wang YY, Liu RX, Intervening effect of Qiangxin Fumai Granule on arrhythmia induced by right coronary artery ischemia/reperfusion in rabbits. Zhongguo Zhong Xi Yi Jie He Za Zhi 2008;28:51-3
   PubMedGoogle Scholar
• Jia Y, Yu L, Chen Y. Effect of dingxin recipe on arrhythmia and injury induced by ischemia and reperfusion in rabbits. Zhongguo Zhong Xi Yi Jie He Za Zhi 1999;19:678-81
   PubMedGoogle Scholar
• Qi H, Hua MJ. Clinical study of the effect of dingxin tablets on tachyarrhythmia. Shandong J Tradit Chin Med 1999;18:438-9
   Google Scholar
• Cheng TJ, Yang JY, Zhu L, The effect of Renqingmangjue capsule against anoxia and arrhythmia. Pharmacol Clin Chin Mater Med 2003;19:40-1
   Google Scholar
• Lin YR, Fang YZ. Effect of Yiqihuoxuetang on 102 cases of arrhythmia. Shaanxi J Tradit Chin Med 2006;17:147-48
   Google Scholar
• Shu LQ, Zhao XH. Clinical observation of the effect of jiaweidingji recipe on tachyarrhythmia. Jilin J Tradit Chin Med 2007;27:4
   Google Scholar
• Hu JL, Huang XZ. Experimental study on the anti-arrhythmic effects of zhigancaotang. Lishizhen Med Mater Med Res 2008;19:5
   Google Scholar
• Zhou F, Hu SJ, Mu Y. Protection effect of Wenxin Keli on isoproterenol induced heart failure in rats. Zhongguo Zhong Yao Za Zhi 2007;32:1676-9
   PubMedGoogle Scholar
• Wen-Feng C, Guo-Fen Q, Yan-Jie L, Flavonoids from Chinese Viscum coloratum: antiarrhythmic efficacy and ionic mechanisms. Phytother Res 2006;20:1100-2
   PubMed Web of Science ®Google Scholar
• Liang Y, Qiu J, Gao HQ, Protective effect of grape seed proanthocyanidins extracts on reperfusion arrhythmia in rabbits. J Nutr Sci Vitaminol (Tokyo) 2009;55:223-30
   PubMed Web of Science ®Google Scholar
• Ding CJ, Liu JT, Wang JX, Protective effect of total flavonoid of Herba Pyrolae on acute myocardial ischemic injury in rats. Zhong Yao Cai 2007;30:1105-9
   PubMedGoogle Scholar
• Zhou F, Hu SJ, Mu Y. Protection effect of Wenxin Keli on isoproterenol induced heart failure in rats. Zhongguo Zhong Yao Za Zhi 2007;32:1676-9
   PubMedGoogle Scholar
• Gao W, Liang RX, Xiao YQ, Protective effect of the pretreatment with Chuanxiong-phthalide A on the vascular endothelial cells impaired by the ischemia and reperfusion in isolated rats hearts. Zhongguo Zhong Yao Za Zhi 2005;30:1448-51
   PubMedGoogle Scholar
• Chen M, Yang ZW, Zhu JT, Anti-arrhythmic effects and electrophysiological properties of Ophiopogon total saponins. Zhongguo Yao Li Xue Ba 1990;11:161-5
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Wang T, Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms. Biochem Biophys Res Commun 2006;340:1192-9
   PubMed Web of Science ®Google Scholar
• Zhang HY, Xu CQ, Li HX, The effect of resveratrol on arrhythmia and cardiac ischemia. Chin Pharmacol Bull 2006;22:383-4
   Google Scholar
• Sun GB, Xu HB, Wen FC, Anti-arrhythmic effect of deglucose-chikusetsu-saponin IVa. Chin J Pharmacol Toxicol 2006;20:377-8
   Google Scholar
• Huang CY, Xie SR, Huang SY, Experimental studies of antiarrhythmic effects of matrine. J Dalian Med Univ 2002;24:177-9
   Google Scholar
• Wang H, Luo SD. Effect of diacetyl-liensinine on experimental arrhythmia. Chin J Hosp Pharm 2001;21:328-30
   Google Scholar
• Xie SR, Huang CY, Huang SY. Antiarrhythmic effect of saponines of leaf of sophoridine, (Sop). J Dalian Med Univ 2002;23:104-7
   Google Scholar
• Xie SR, Huang CY, Huang SY, Antiarrhythmic effect of glycyrrhetinic acid. Herald Med 2004;23:140-2
   Google Scholar
• OYang CH, Wu JL. Anti-arrhythmic effects of baicalin. J Xianning Med Coll 2002;16:7-10
   Google Scholar